“I want to make memories with my kids and be there for them as they grow up. I’m determined to do everything I can to make that happen,” she says. “The funding could not only give me peace of mind but also mean more time to create those lasting memories.”
Patient perspective – 28-year-old Finlay Bergin’s story
“This is amazing. Because the biggest stress since my melanoma diagnosis has been money related”
Good news for many advanced melanoma patients in New Zealand
Good news for many advanced melanoma patients in New Zealand. Melanoma New Zealand welcomes today’s news from Pharmac for increased and new access to funded medicines because it’s long-awaited good news for many New Zealand patients with advanced melanoma.
Progress towards melanoma drug funding
Today Pharmac has released consultation on a proposal which means that from 1 June 2025 many advanced melanoma patients in New Zealand could have access to some melanoma drugs for which they were previously ineligible.
Pharmac Funding Boost Announcement
Although yesterday’s announcement of a Pharmac funding boost is a significant and positive step for medicines access in New Zealand, uncertainty and concern remain for many melanoma patients in New Zealand.
An urgent call to arms for political action on cancer
CANGO (Cancer Non-Governmental Organisations) is an alliance of prominent cancer charities.
